Evolv Technology Selected as American Hospital Association’s Preferred Physical Security Provider

Download as PDF

WALTHAM, Mass.--(BUSINESS WIRE)-- Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leader in AI‑powered weapons detection and security screening systems, today announced it has been selected by the American Hospital Association (AHA) as a Preferred Physical Security Provider for hospitals and health systems. Over 70% of workplace violence takes place in healthcare settings and many hospital leaders are adopting advanced security technology to reduce risk and protect their patients, staff and visitors. Evolv is the only concealed weapons detection provider to be selected for the AHA’s program.

The AHA Preferred Cybersecurity and Risk Provider Program uses a rigorous, multi-step vetting process to identify trusted, high-reputation companies and their solutions for its member hospitals. This process includes an initial vetting, a full review of services by an expert team, and submission of hospital references.

“Evolv has been selected by the AHA as an excellent solution provider for their AI‑powered weapons detection and security screening systems,” said John Riggi, National Advisor for Cybersecurity and Risk at the AHA. “We can confidently recommend Evolv as a reliable source of support for our nation’s hospitals and health systems in their efforts to protect their patients and staff from harm.”

Evolv’s AI‑powered weapons detection systems are designed to help hospitals and health systems address growing safety concerns while maintaining efficient, welcoming environments. Evolv partners with over 500 hospital buildings across North America and screens over 900,000 hospital visitors and staff each day.

“Healthcare leaders are balancing the critical need for safety with the responsibility to preserve patient access and experience,” said Jason Grellner, VP of Healthcare for Evolv Technology. “We are honored to be recognized by the AHA and to support hospitals and health systems nationwide as they work to protect the people who depend on them every day.”

As part of the AHA’s commitment to helping healthcare organizations address the growing threat of hospital violence, the association recently released a Leadership Guide developed in partnership with the FBI’s Behavioral Analysis. Its purpose is to provide a comprehensive overview of management approaches and security measures aimed at reducing violence.

About Evolv Technology

Evolv (NASDAQ: EVLV) is designed to transform human security by helping organizations detect potential threats, mitigate risk, and enhance safety using AI-powered security solutions with robust insights. Our technology has helped to create efficient and positive security screening experiences for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces. Evolv’s mission is to create a safer world to live, work, learn, and play. Evolv’s advanced systems have scanned more than 3 billion people since 2019. Evolv Express® has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) and Evolv eXpedite™ has been awarded the Safety Act Developmental Testing and Evaluation Designation. Evolv and its products have been awarded numerous awards which can be viewed on our Certifications and Awards web page. Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

About The American Hospital Association

The American Hospital Association (AHA) is the national organization that represents and serves all types of hospitals, health care networks, and their patients and communities. Nearly 5,000 hospitals, health care systems, networks, other providers of care and 43,000 individual members come together to form the AHA.

Through representation and advocacy activities, AHA ensures that members' perspectives and needs are heard and addressed in national health policy development, legislative and regulatory debates, and judicial matters. The AHA’s advocacy efforts include the legislative and executive branches and include the legislative and regulatory arenas.

Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Evolv Technology intends for such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this press release, other than that are historical facts, are statements that could be deemed forward-looking statements, including statements made by the President and Chief Executive Officer, as well as statements regarding the Company’s strategy, financial and operational performance and growth, and efforts to create value for stakeholders. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause actual results and actions to be materially different from any future results or actions expressed or implied by the forward-looking statements, including, but not limited to, the factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on April 28, 2025 , as well as any such factors that may be updated from time to time in our other filings with the SEC. The forward-looking statements in this press release are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this document, whether as a result of any new information, future events or otherwise.

Evolv Media Contact:
Alexandra Smith Ozerkis
aozerkis@evolvtechnology.com

Evolv Investor Contact:
Brian Norris
bnorris@evolvtechnology.com

Source: Evolv Technologies Holdings, Inc.

Released February 26, 2026